BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27346425)

  • 1. Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks.
    Rendeiro AF; Schmidl C; Strefford JC; Walewska R; Davis Z; Farlik M; Oscier D; Bock C
    Nat Commun; 2016 Jun; 7():11938. PubMed ID: 27346425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia.
    Beekman R; Chapaprieta V; Russiñol N; Vilarrasa-Blasi R; Verdaguer-Dot N; Martens JHA; Duran-Ferrer M; Kulis M; Serra F; Javierre BM; Wingett SW; Clot G; Queirós AC; Castellano G; Blanc J; Gut M; Merkel A; Heath S; Vlasova A; Ullrich S; Palumbo E; Enjuanes A; Martín-García D; Beà S; Pinyol M; Aymerich M; Royo R; Puiggros M; Torrents D; Datta A; Lowy E; Kostadima M; Roller M; Clarke L; Flicek P; Agirre X; Prosper F; Baumann T; Delgado J; López-Guillermo A; Fraser P; Yaspo ML; Guigó R; Siebert R; Martí-Renom MA; Puente XS; López-Otín C; Gut I; Stunnenberg HG; Campo E; Martin-Subero JI
    Nat Med; 2018 Jun; 24(6):868-880. PubMed ID: 29785028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative epigenomics in chronic lymphocytic leukaemia: Biological insights and clinical applications.
    Kulis M; Martin-Subero JI
    Br J Haematol; 2023 Feb; 200(3):280-290. PubMed ID: 36121003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL.
    Rendeiro AF; Krausgruber T; Fortelny N; Zhao F; Penz T; Farlik M; Schuster LC; Nemc A; Tasnády S; Réti M; Mátrai Z; Alpár D; Bödör C; Schmidl C; Bock C
    Nat Commun; 2020 Jan; 11(1):577. PubMed ID: 31996669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleosome repositioning in chronic lymphocytic leukemia.
    Piroeva KV; McDonald C; Xanthopoulos C; Fox C; Clarkson CT; Mallm JP; Vainshtein Y; Ruje L; Klett LC; Stilgenbauer S; Mertens D; Kostareli E; Rippe K; Teif VB
    Genome Res; 2023 Oct; 33(10):1649-1661. PubMed ID: 37699659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.
    Gaiti F; Chaligne R; Gu H; Brand RM; Kothen-Hill S; Schulman RC; Grigorev K; Risso D; Kim KT; Pastore A; Huang KY; Alonso A; Sheridan C; Omans ND; Biederstedt E; Clement K; Wang L; Felsenfeld JA; Bhavsar EB; Aryee MJ; Allan JN; Furman R; Gnirke A; Wu CJ; Meissner A; Landau DA
    Nature; 2019 May; 569(7757):576-580. PubMed ID: 31092926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of
    Poppova L; Pavlova S; Gonzalez B; Kotaskova J; Plevova K; Dumbovic G; Janovska P; Bystry V; Panovska A; Bezdekova L; Maslejova S; Brychtova Y; Doubek M; Krzyzankova M; Borsky M; Mayer J; Bryja V; Alonso S; Pospisilova S
    Epigenetics; 2022 Dec; 17(12):1628-1635. PubMed ID: 35333703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.
    Nadeu F; Royo R; Clot G; Duran-Ferrer M; Navarro A; Martín S; Lu J; Zenz T; Baumann T; Jares P; Puente XS; Martín-Subero JI; Delgado J; Campo E
    Blood; 2021 May; 137(21):2935-2946. PubMed ID: 33211804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics.
    Speedy HE; Beekman R; Chapaprieta V; Orlando G; Law PJ; Martín-García D; Gutiérrez-Abril J; Catovsky D; Beà S; Clot G; Puiggròs M; Torrents D; Puente XS; Allan JM; López-Otín C; Campo E; Houlston RS; Martín-Subero JI
    Nat Commun; 2019 Aug; 10(1):3615. PubMed ID: 31399598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks.
    Mallm JP; Iskar M; Ishaque N; Klett LC; Kugler SJ; Muino JM; Teif VB; Poos AM; Großmann S; Erdel F; Tavernari D; Koser SD; Schumacher S; Brors B; König R; Remondini D; Vingron M; Stilgenbauer S; Lichter P; Zapatka M; Mertens D; Rippe K
    Mol Syst Biol; 2019 May; 15(5):e8339. PubMed ID: 31118277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV
    Burns A; Alsolami R; Becq J; Stamatopoulos B; Timbs A; Bruce D; Robbe P; Vavoulis D; Clifford R; Cabes M; Dreau H; Taylor J; Knight SJL; Mansson R; Bentley D; Beekman R; Martín-Subero JI; Campo E; Houlston RS; Ridout KE; Schuh A
    Leukemia; 2018 Feb; 32(2):332-342. PubMed ID: 28584254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Tsagiopoulou M; Moysiadis T; Bhoi S; Malousi A; Psomopoulos F; Mansouri L; Laidou S; Papazoglou D; Gounari M; Pasentsis K; Plevova K; Kuci-Emruli V; Duran-Ferrer M; Davis Z; Ek S; Rossi D; Gaidano G; Ritgen M; Oscier D; Stavroyianni N; Pospisilova S; Davi F; Ghia P; Hadzidimitriou A; Belessi C; Martin-Subero JI; Pott C; Rosenquist R; Stamatopoulos K
    Int J Cancer; 2019 Jun; 144(11):2695-2706. PubMed ID: 30447004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
    Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
    Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sc-compReg enables the comparison of gene regulatory networks between conditions using single-cell data.
    Duren Z; Lu WS; Arthur JG; Shah P; Xin J; Meschi F; Li ML; Nemec CM; Yin Y; Wong WH
    Nat Commun; 2021 Aug; 12(1):4763. PubMed ID: 34362918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
    Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.